CD4 and myeloid sarcoma: Characterization of CD4+ T-cell responses in MS patients also showed dysregulation with strikingly elevated frequencies of EBNA-1-specific CD4+ memory T cells, with increased proliferative capacity and enhanced IFN-γ production (40, 75).